Biography/Memoir

Compass… updates on [synthetic polymorph] psilocybin…

Compass sinks after depression therapy results… the net loss for the year [2021] was $71.7 million…

 …Compass doesn’t have any meaningful revenue… continues to explore… indications and therapeutic approaches… there were 12 people in the [synthetic psilocybin polymorph] study… who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves.

Original Article (Green Market Report & Bloomberg):
Compass gives updates on psilocybin research in earnings release
& Compass sinks after depression therapy results fuel concerns
Artwork Fair Use: Audrius Meskauskas

Biography/Memoir

…launch of…